Brief: Uniqure Announces Sale Of Commercial Manufacturing Facility To Genezen
01/07/2024 12:08
July 1 (Reuters) - Uniqure NV UQ1.F :
* UNIQURE ANNOUNCES SALE OF COMMERCIAL MANUFACTURING
FACILITY TO
GENEZEN
* UNIQURE TO REDUCE CASH BURN BY $40 MILLION PER YEAR AND
RECEIVE
TOTAL CONSIDERATION OF $25 MILLION
* REVIEW OF OPERATIONS IS ONGOING AND EXPECTED TO BE
COMPLETE IN
Q3 OF 2024
Source text for Eikon: ID:nGNE32dsmf
Further company coverage: UQ1.F
((Reuters.Briefs@thomsonreuters.com;))
Recent news on uniQure
See all newsuniQure tumbles after updated Huntington's disease gene therapy data
UniQure plunges as Huntington's trial data disappoints investors (updated)
uniQure tumbles after updated Huntington's disease gene therapy data
UniQure's Huntington's therapy fails to significantly slow disease progression in trial
uniQure seeks US approval for Huntington's gene therapy after FDA reversal